Search

everythinglearnresearchcommunity

for

Search:↓

The U.K. created the CPSA to set safety standards for non-surgical cosmetic treatments and improve patient protection.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

New method accurately measures finasteride in tablets and bulk.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

4-aminopyridine, a FDA-approved drug, speeds up skin wound healing and tissue regeneration.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Platelet-rich plasma is considered safe but needs more research to prove its effectiveness in medical treatments.

Proretinal nanoparticles improve skin absorption and reduce irritation of topical retinoids.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

P-3074 effectively blocks scalp DHT better than oral finasteride.

SEPA™ enhances the effectiveness of minoxidil in stimulating hair growth, working faster and better than Rogaine® TS, with no significant side effects.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

AFL is safe and effective for topical drug delivery but needs larger studies and cheaper devices for wider use.

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

PRP speeds up healing with few side effects, but more research is needed to standardize its use.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Combining PRP with Procapil is more effective for hair loss treatment than PRP alone.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Paroxetine relieves pain by increasing allopregnanolone levels.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.